diarrhea retatrutide Significantly Reduces Visceral Fat in Clinical Trials Annals - Retatrutide, a triple-hormone
Description
GLP-1 medications like Ozempic and Wegovy have surged in popularity, but so have scams targeting people eager to access the drugs or products claiming to deliver similar results
Right now, that means three things: Patients taking GLP-1 medications should proactively flag this to their dentist at every appointment Dentists should be asking every patient whether they are on weight-loss medication as a standard part of their clinical intake Prescribers should include oral health explicitly in the side effect briefing given to patients starting these drugs The data shows that awareness is rising
Supplements are meant to fill those dietary gaps, not substitute whole foods altogether
The clinical infrastructure is solid: named pharmacy partners, LegitScript certification, and a compliant telehealth backend through CareGLP
Available from: National Institute for Health and Care Excellence (NICE)
